CytoMed Therapeutics Limited Cash Flows From Used In Operating Activities
CytoMed Therapeutics Limited (GDTC) reported Cash Flows From Used In Operating Activities of -SGD 3.70 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:CashFlowsFromUsedInOperatingActivities · last filed 2026-03-31
SGD
| Period end | Cash Flows From Used In Operating Activities 12 month | Cash Flows From Used In Operating Activities 12 month as first filed |
|---|---|---|
| 2025-12-31 | -3.70M SGD 20-F · filed 2026-03-31 | |
| 2024-12-31 | -2.71M SGD 20-F · filed 2026-03-31 | |
| 2023-12-31 | -3.53M SGD 20-F · filed 2026-03-31 | -3.43M SGD 20-F · filed 2024-04-22 |
| 2022-12-31 | -1.40M SGD 20-F · filed 2025-04-28 | |
| 2021-12-31 | -1.71M SGD 20-F · filed 2024-04-22 | |
| 2020-12-31 | -849.44K SGD 20-F · filed 2023-05-01 |
USD
| Period end | Cash Flows From Used In Operating Activities 12 month |
|---|---|
| 2025-12-31 | -$2.88M 20-F · filed 2026-03-31 |
| 2024-12-31 | -$1.98M 20-F · filed 2025-04-28 |
| 2023-12-31 | -$2.60M 20-F · filed 2024-04-22 |
| 2022-12-31 | -$1.04M 20-F · filed 2023-05-01 |